XTI Aerospace, Inc. current report, 14 January 2020

Business Context and Reporting Period

This Form 8-K is filed by Inpixon (not XTI Aerospace, Inc., as indicated in the metadata) for the reporting period of January 14, 2020. The filing details a material definitive agreement involving the exchange of debt for equity.

Key Financial Metrics and Transaction Details

  • Debt Reduction: The Company reduced its outstanding debt by $1,500,000 through the partition and exchange of a promissory note originally issued on May 3, 2019.
  • Equity Issuance: The Company issued 410,958 shares of Common Stock to Chicago Venture Partners, L.P. (CVP).
  • Effective Price: The exchange occurred at an effective price of $3.65 per share.
  • Remaining Debt to CVP: As of December 31, 2019, CVP held other promissory notes with an aggregate balance of approximately $4.17 million.
  • Related Party Debt: Affiliates of CVP held additional notes as of December 31, 2019: Iliad Research and Trading, L.P. ($1.2 million) and St. George Investments LLC ($962,873).
  • Capital Structure: As of January 14, 2020, total outstanding Common Stock was approximately 4,645,880 shares (including the new issuance).

Material Changes

The primary material change is the conversion of a portion of the Company's debt obligations into equity. This transaction reduces the Company's interest-bearing liabilities by $1.5 million while increasing the number of outstanding shares by 410,958. The filing does not provide comparative revenue, profit, or cash flow data for the period.

Guidance, Risks, and Unusual Items

  • Unregistered Sale: The shares were issued pursuant to an exemption from registration under Section 3(a)(9) of the Securities Act of 1933, as they were exchanged for an existing security (the note) with no additional consideration or commissions paid.
  • Delivery Terms: Shares were to be delivered to CVP on or before January 16, 2020, contingent upon the note being surrendered and held by CVP's brokerage firm for public resale.
  • Outstanding Warrants: The filing notes the existence of warrants to purchase approximately 2,507 shares at $149.85 per share and 4,758 shares at $12.49 per share.
  • Financial Outlook: The filing text does not provide management commentary, forward-looking guidance, or specific risk factors beyond the transaction details.

Investor Verification Checklist

  • Verify the total outstanding debt balance of Inpixon following the $1.5 million reduction.
  • Confirm the dilution impact of the 410,958 new shares on existing shareholders.
  • Review the terms of the remaining $4.17 million in notes held by CVP and the affiliate notes totaling over $2.1 million.
  • Check the status of the Series 4 and Series 5 Convertible Preferred Stock and their potential conversion impact.
  • Confirm the effective date of the share delivery and the public resale status of the shares.